Key facts
- Cormorant Asset Management, LP filed SCHEDULE 13G/A for Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP).
- Disclosed ownership: 6.2%.
- Date of event: 31 Mar 2026.
Cormorant Asset Management, LP - 31 Mar 2026 SCHEDULE 13G/A Report for Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP)
- Filing Manager
- Cormorant Asset Management, LP
- Reporting Manager
- Cormorant Asset Management, LP
- Symbol
- RAPP
- Shares outstanding
- 47,779,015 shares
- Disclosed Ownership
- 2,957,521 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 13:28:29 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 17 Feb 2026
- SEC
- View on sec.gov
Key filing fact
Cormorant Asset Management, LP disclosed 6.2% ownership in Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP) on 31 Mar 2026.
Change
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 15 May 2026, 13:28.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 6.2% | 2,957,521 | 0 | 2,957,521 | /s/ Bihua Chen | Bihua Chen, Managing Member | |
| Bihua Chen | 6.2% | 2,957,521 | 0 | 2,957,521 | /s/ Bihua Chen | Bihua Chen |
CIK / CUSIP context first